EUVIMEDEUVIMED entdecken
Crossref

Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study

Mathurin Fumery, Claire Dupont, Delphine Ley, Guillaume Savoye, Valérie Bertrand, Nathalie Guillon, Pauline Wils, Corinne Gower-Rousseau, Helene Sarter, Dominique Turck, Ariane Leroyer

Digestive and Liver Disease · 2024

DOI: 10.1016/j.dld.2023.04.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Mathurin Fumery und 10 weiteren Autor:innen. Beteiligte Einrichtung: Amiens University Hospital, Gastroenterology, Amiens, France. Electronic address: fumery.mathurin@chu-amiens.fr. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Association Francois Aupetit, Institut National de la Santé et de la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesAdolescentChildFemaleHumansYoung AdultAdalimumabInfliximabRetrospective StudiesTumor Necrosis Factor InhibitorsTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

Crohn's diseaseLoss of responsePrimary non-responseUlcerative colitisanti-TNF

Substanzen

AdalimumabInfliximabTumor Necrosis Factor InhibitorsTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Amiens University Hospital, Gastroenterology, Amiens, France. Electronic address: fumery.mathurin@chu-amiens.fr.
  • Caen University hospital, Pediatrics, Gastroenterology, France.
  • CHU Lille, Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Lille, France; Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-590…
  • Rouen University Hospital, Gastroenterology, Rouen, France.
  • Le Havre Hospital, Pediatrics, Le Havre, France.
  • Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France; Reims University Hospital, Gastroenterology, Reims, France.

Förderung

  • Association Francois Aupetit
  • Institut National de la Santé et de la Recherche Médicale

Zitieren

APA

Fumery, M., Dupont, C., Ley, D., Savoye, G., Bertrand, V., Guillon, N., Wils, P., Gower-Rousseau, C., Sarter, H., Turck, D., & Leroyer, A. (2024). Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2023.04.017

Vancouver

Fumery M, Dupont C, Ley D, Savoye G, Bertrand V, Guillon N, et al. Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2023.04.017

BibTeX
@article{Fumery2024,
  author = {Fumery, Mathurin and Dupont, Claire and Ley, Delphine and Savoye, Guillaume and Bertrand, Valérie and Guillon, Nathalie and Wils, Pauline and Gower-Rousseau, Corinne and Sarter, Helene and Turck, Dominique and Leroyer, Ariane},
  title = {Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study},
  journal = {Digestive and Liver Disease},
  year = {2024},
  doi = {10.1016/j.dld.2023.04.017}
}
Kostenlos starten →